Synthesis and evaluation of potent and selective β3 adrenergic receptor agonists containing acylsulfonamide, sulfonylsulfonamide, and sulfonylurea carboxylic acid isosteres

被引:48
作者
Uehling, DE [1 ]
Donaldson, KH
Deaton, DN
Hyman, CE
Sugg, EE
Barrett, DG
Hughes, RG
Reitter, B
Adkison, KK
Lancaster, ME
Lee, F
Hart, R
Paulik, MA
Sherman, BW
True, T
Cowan, C
机构
[1] GlaxoSmithKline, Dept Med Chem, Res Triangle Pk, NC 27709 USA
[2] GlaxoSmithKline, Dept Res Bioanal & Drug Metab, Res Triangle Pk, NC 27709 USA
[3] GlaxoSmithKline, Dept Pharmacol, Res Triangle Pk, NC 27709 USA
[4] GlaxoSmithKline, Dept Receptor Biol, Res Triangle Pk, NC 27709 USA
关键词
D O I
10.1021/jm0101500
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Starting from phenethanolamine aniline leads 3a and 3b, we have identified a series of functionally potent and selective beta(3) adrenergic receptor (AR) agonists containing acylsulfonamide, sulfonylsulfonamide, or sulfonylurea groups within the aniline phenethanolamine series. In beta(3) beta(2), and beta(1) AR cAMP functional assays, 3a and other right-hand side (RHS) carboxylate analogues were found to be full agonists that were modestly selective against beta(1) or beta(2) ARs, while analogues lacking RHS acid functionality were active at beta(3) AR but not selective. Replacement of the carboxylate with acylthiazole and acylmethylsulfone gave potent, but only modestly selective, compounds. Increasing the size of the RHS sulfonamide substituent with phenyl or p-toluene afforded compounds with good potency and functional selectivity (beta(3) AR pEC(50) greater than 8; beta(1) and beta(2) AR selectivity greater than 40- and 500-fold, respectively). Our SAR studies suggest that the potency and selectivity profile of the best analogues reported here is a result of both the steric bulk and acidity of the RHS sulfonamide NH group. Although all of the analogues had a pharmacokinetic half-life of less than 2 h, acylsulfonamides 43 and 44 did show moderately low clearance in dogs. These two compounds were further evaluated by thermographic imaging in mice and were found to produce a robust thermogenic response via oral administration.
引用
收藏
页码:567 / 583
页数:17
相关论文
共 43 条
  • [11] Discovery of an orally bioavailable alkyl oxadiazole β3 adrenergic receptor agonist
    Feng, DQD
    Biftu, T
    Candelore, MR
    Cascieri, MA
    Colwell, LF
    Deng, LP
    Feeney, WP
    Forrest, MJ
    Hom, GJ
    MacIntyre, DE
    Miller, RR
    Stearns, RA
    Strader, CD
    Tota, L
    Wyvratt, MJ
    Fisher, MH
    Weber, AE
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (13) : 1427 - 1429
  • [12] A selective human β3 adrenergic receptor agonist increases metabolic rate in rhesus monkeys
    Fisher, MH
    Amend, AM
    Bach, TJ
    Barker, JM
    Brady, EJ
    Candelore, MR
    Carroll, D
    Cascieri, MA
    Chiu, SHL
    Deng, LP
    Forrest, MJ
    Hegarty-Friscino, B
    Guan, XM
    Hom, GJ
    Hutchins, JE
    Kelly, LJ
    Mathvink, RJ
    Metzger, JM
    Miller, RR
    Ok, HO
    Parmee, ER
    Saperstein, R
    Strader, CD
    Stearns, RA
    Thompson, GM
    Tota, L
    Vicario, PP
    Weber, AE
    Woods, JW
    Wyvratt, MJ
    Zafian, PT
    MacIntyre, DE
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (11) : 2387 - 2393
  • [13] FOXTON MW, 1995, Patent No. 9533724
  • [14] Hypertrophy of brown adipocytes in brown and white adipose tissues and reversal of diet-induced obesity in rats treated with a beta(3)-adrenoceptor agonist
    Ghorbani, M
    Claus, TH
    HimmsHagen, J
    [J]. BIOCHEMICAL PHARMACOLOGY, 1997, 54 (01) : 121 - 131
  • [15] GRANNEMAN JG, 1992, MOL PHARMACOL, V42, P964
  • [16] GRANNEMAN JG, 1991, MOL PHARMACOL, V40, P895
  • [17] HARTLEY CD, 1997, Patent No. 9721666
  • [18] Multilocular fat cells in WAT of CL-316243-treated rats derive directly from white adipocytes
    Himms-Hagen, J
    Melnyk, A
    Zingaretti, MC
    Ceresi, E
    Barbatelli, G
    Cinti, S
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2000, 279 (03): : C670 - C681
  • [19] SELECTIVE BETA-3-ADRENERGIC AGONISTS OF BROWN ADIPOSE-TISSUE AND THERMOGENESIS .1. [4-[2-[(2-HYDROXY-3-PHENOXYPROPYL)AMINO]ETHOXY]PHENOXY]ACETATES
    HOWE, R
    RAO, BS
    HOLLOWAY, BR
    STRIBLING, D
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (10) : 1751 - 1759
  • [20] Howe Ralph, 1993, Drugs of the Future, V18, P529